US OptionsDetailed Quotes
GILD240809P62000
- 0.04
- +0.03+300.00%
15min DelayClose Aug 8 16:00 ET
0.04High0.04Low
0.04Open0.01Pre Close39 Volume5 Open Interest62.00Strike Price156.00Turnover175.87%IV18.03%PremiumAug 9, 2024Expiry Date0.00Intrinsic Value100Multiplier1DDays to Expiry0.04Extrinsic Value100Contract SizeAmericanOptions Type-0.0221Delta0.0069Gamma1162.92Leverage Ratio-0.0650Theta-0.0001Rho-25.69Eff Leverage0.0023Vega
Gilead Sciences Stock Discussion
Sign in to post a comment
After the S&P 500 had its worst day since 2022 Monday, it rebounded with its best one day point climb since January of 2023 Thursday.
Just past the 4 pm ET close, the $S&P 500 Index (.SPX.US)$ climbed 2.30%, the $Dow Jones Industrial Average (.DJI.US)$ climbed 1.76%, and the $Nasdaq Composite Index (.IXIC.US)$ climbed 2.87%.
MACRO
Thursday in macroeconomics, initial jobless claims came in at 233k, lower than 250k l...
Just past the 4 pm ET close, the $S&P 500 Index (.SPX.US)$ climbed 2.30%, the $Dow Jones Industrial Average (.DJI.US)$ climbed 1.76%, and the $Nasdaq Composite Index (.IXIC.US)$ climbed 2.87%.
MACRO
Thursday in macroeconomics, initial jobless claims came in at 233k, lower than 250k l...
24
8
🚨 This Week’s PDUFA:
$Humacyte (HUMA.US)$ : 🤔
⇨ Human Acellular Vessel (HAV)™
‣ Vascular Trauma
‣ PDUFA: 8/10/24 (BLA)
🗓️ Last Week’s AdCom & PDUFAs:
$Zevra Therapeutics (ZVRA.US)$ : Favorable AdCom 👍
🗳️ 11-5 votes in favor
⇨ Arimoclomol
‣ Niemann-Pick disease type C
‣ AdCom: 8/2/24 (NDA)
$Adaptimmune Therapeutics (ADAP.US)$ : Approved 🎉
⇨ TECELRA (afamitresgene autoleucel)
‣ Synovial sarcoma
‣ PDUFA: 8/4/24 (BLA)
$GlaxoSmithKline (GSK.US)$ : Approved 🎉
⇨ Jemperli
‣ Endometria...
$Humacyte (HUMA.US)$ : 🤔
⇨ Human Acellular Vessel (HAV)™
‣ Vascular Trauma
‣ PDUFA: 8/10/24 (BLA)
🗓️ Last Week’s AdCom & PDUFAs:
$Zevra Therapeutics (ZVRA.US)$ : Favorable AdCom 👍
🗳️ 11-5 votes in favor
⇨ Arimoclomol
‣ Niemann-Pick disease type C
‣ AdCom: 8/2/24 (NDA)
$Adaptimmune Therapeutics (ADAP.US)$ : Approved 🎉
⇨ TECELRA (afamitresgene autoleucel)
‣ Synovial sarcoma
‣ PDUFA: 8/4/24 (BLA)
$GlaxoSmithKline (GSK.US)$ : Approved 🎉
⇨ Jemperli
‣ Endometria...
4
$Vir Biotechnology (VIR.US)$ Good news is my position in GILD is safe. Sick but hell if you boost price to 20, I’ll love to leave. Oncology is crowded path, bad idea.
your own platform is most valuable and made 2 Billion for the company. You just let people go…
your own platform is most valuable and made 2 Billion for the company. You just let people go…
2
$Immuneering (IMRX.US)$ $SPDR S&P Biotech ETF (XBI.US)$ $iShares Biotechnology ETF (IBB.US)$ $S&P 500 Index (.SPX.US)$ $BioAtla (BCAB.US)$ $Gilead Sciences (GILD.US)$ $Affimed NV (AFMD.US)$ $Instil Bio (TIL.US)$ $Nkarta (NKTX.US)$
Biotech stocks remain depressed, nearly two years into a dip that has seen the SPDR S&P Biotech ETF XBI 0.05% drop nearly 50%.
The other most-watched exchange-traded fund that tracks the biotech secto...
Biotech stocks remain depressed, nearly two years into a dip that has seen the SPDR S&P Biotech ETF XBI 0.05% drop nearly 50%.
The other most-watched exchange-traded fund that tracks the biotech secto...
8
1
Morning Movers
Gapping up
$Boeing (BA.US)$ stock rose 0.90% after the aircraft manufacturer agreed to plead guilty to a criminal fraud conspiracy charge to resolve a U.S. Justice Department investigation into two 737 MAX fatal crashes and will pay a $243.6 million fine.
$Paramount Global-B (PARA.US)$ stock rose 2.87% after Skydance Media agreed to acquire the entertainment giant, with the overall deal valued at over $8 billion....
Gapping up
$Boeing (BA.US)$ stock rose 0.90% after the aircraft manufacturer agreed to plead guilty to a criminal fraud conspiracy charge to resolve a U.S. Justice Department investigation into two 737 MAX fatal crashes and will pay a $243.6 million fine.
$Paramount Global-B (PARA.US)$ stock rose 2.87% after Skydance Media agreed to acquire the entertainment giant, with the overall deal valued at over $8 billion....
Expand 39
5
Morning Movers
Gapping up
$Nike (NKE.US)$ Oppenheimer raised Nike's stock rating from Perform to Outperform. Shares increased by 1.29% in premarket trading.
See how Nike's options are moving today.
$Amazon (AMZN.US)$ 's stock increased by 0.2% following reports of the company's plans to overhaul its Alexa service, aiming to transform the money-losing venture by incorporating a conversational generative AI and offering two levels...
Gapping up
$Nike (NKE.US)$ Oppenheimer raised Nike's stock rating from Perform to Outperform. Shares increased by 1.29% in premarket trading.
See how Nike's options are moving today.
$Amazon (AMZN.US)$ 's stock increased by 0.2% following reports of the company's plans to overhaul its Alexa service, aiming to transform the money-losing venture by incorporating a conversational generative AI and offering two levels...
33
3
2
No comment yet
104247826 :![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
104476495 : hi
On Paris : Good morning
affable Blobfish_403 : With the US economy and stock market being so strong, Wall Street is making public opinion what is the purpose of cutting interest rates?
Laine Ford : maybe in my future
View more comments...